This is particularly relevant for SMARCA4 which is mutatedin many cancer cell lines as well as patient samples [51] but was not significantlyoverexpressed at a protein level in ovarian cancer compared to normal tissues. This evidence concerns the gene SMARCA4 and ovarian carcinoma.